Anti-inflammatory effects of pioglitazone in acute stroke - a double-blind placebo controlled trial

Phase 4

• Conditions: Acute stroke; Stroke - Ischaemic

• Registration Number: ACTRN12605000174684
• Lead Sponsor: Dr R W Simpson

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Diabetes, acute ischaemic stroke.

Exclusion Criteria

Contra-indication to pioglitazone, unable to obtain consent, pregnant, severe inflammatory illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effect on various inflammatory markers[At days 1, 3, 5, 7 and 14 after stroke.]

Secondary Outcome Measures

Name	Time	Method
Stroke size and disability[At 14 days.]